ALICIA REIMONDO: Open Payments
NPI 1295254787 · WEST AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,973 in 108 payments from 25 companies in 2025. Trend: 2023 $1,909 · 2024 $1,141 · 2025 $1,973
Food & beverage: $1,973
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $340 |
| Lilly USA, LLC | 15 | $296 |
| PFIZER INC. | 14 | $186 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $136 |
| ABBVIE INC. | 5 | $107 |
| Exact Sciences Corporation | 4 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $97 |
| GlaxoSmithKline, LLC. | 6 | $96 |
| Astellas Pharma US Inc | 3 | $70 |
Products named: MOUNJARO, Wegovy, JARDIANCE, CAPLYTA, ZEPBOUND, NURTEC ODT, Cologuard Collection Kit, XIFAXAN.
Industry payments across NY — which companies pay providers there.
